Latest News
UCLA to launch Genetic Signatures technology after successful completion of study
- UCLA successfully completes Genetic Signatures product trial
- Study demonstrates GSS 3Base™ technology & products as globally impactful
- Trial results to be officially published by UCLA
Molecular diagnostics company Genetic Signatures Ltd (ASX: GSS) is pleased to announce that the University of California, Los Angeles (UCLA) has notified the Company that a recent GSS product evaluation was successful and showed improved pathogen detection compared to traditional methods.
“We are very pleased with our study results and look forward to working with Genetic Signatures to focus on the best technologies to enhance patient care,” said Romney Humphries, PhD D(ABMM), Section Chief, Clinical Microbiology UCLA. “We will soon be sharing our results in upcoming publications highlighting the infections that can be missed with traditional methods”
